Risk of Substance Use Disorder Among Patients With Autism

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 4, 2021

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5371?guestAccessKey=c6dd8dcf-daf6-427f-bd94-e126b67fc46d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010421

 

What The Study Did: Researchers used health insurance data from Taiwan to investigate the risk of substance use disorder among patients with autism spectrum disorder and its associations with risk of death.

Authors: Chih-Sung Liang, M.D., of the National Defense Medical Center, and Mu-Hong Chen, M.D., Ph.D., of the Taipei Veterans General Hospital in Taipei, Taiwan, are the corresponding authors.

 

(doi:10.1001/jamapediatrics.2020.5371)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.